| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
36 companies
Orbimed Advisors LLC is a Director, 10% Owner at EWTX with holdings across 36 companies. Recent SEC Form 4 filings include 5 buys and 23 sells.
Estimated insider holdings value: $2053.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2024 | TERN Terns Pharmaceuticals, Inc. | Director, 10% Owner | Sell | 56,164 | $10.00 | $561,640.00 | -0.4% | -21.4% | -45.7% | |
| Jul 2, 2024 | TELA Tela Bio, Inc. | 10% Owner | Sell | 428,300 | $4.72 | $2,022,000.00 | -5.5% | -45.1% | -58.6% | |
| Jun 17, 2024 | IRON Disc Medicine, Inc. | Director | Buy | 83,334 | $36.00 | $3,000,024.00 | +4.9% | +6.3% | +11.6% | |
| May 16, 2024 | ELVN Enliven Therapeutics, Inc. | Director, 10% Owner | Sell | 1,033,300 | $22.14 | $22,877,262.00 | -11.5% | -8.4% | -29.2% | |
| May 3, 2024 | NPCE Neuropace Inc | 10% Owner | Sell | 29,206 | $14.02 | $409,426.44 | -0.3% | -47.1% | -12.2% | |
| Apr 24, 2024 | NPCE Neuropace Inc | 10% Owner | Sell | 1,781 | $14.06 | $25,040.86 | - | -37.6% | -17.0% | |
| Apr 23, 2024 | NPCE Neuropace Inc | 10% Owner | Sell | 64,653 | $14.12 | $913,056.90 | -0.6% | -45.4% | -22.1% | |
| Apr 18, 2024 | NPCE Neuropace Inc | 10% Owner | Sell | 16,992 | $14.02 | $238,231.07 | -0.2% | -46.4% | -22.9% | |
| Apr 12, 2024 | NPCE Neuropace Inc | 10% Owner | Sell | 485,000 | $14.49 | $7,026,032.93 | -6.4% | -45.1% | -22.8% | |
| Jan 30, 2024 | AVBP Arrivent Biopharma, Inc. | Director, 10% Owner | Buy | 444,444 | $18.00 | $7,999,992.00 | +17.2% | -25.7% | +31.9% |